CKD News

    Skip to content
    • Home
    • About Us
    • Contact Us
    February 24, 2017

    Phase 2/3 Trial Will Evaluate Bardoxolone Methyl as Treatment for Alport-related CKD

    News
    Reata Pharmaceuticals has begun screening patients for the new Phase 2/3 trial evaluating bardoxolone methyl as a treatment for patients of Alport syndrome-associated chronic kidney disease (CKD). The aim of ... Read more
    February 22, 2017

    Study Identifies CKD Patient Risk Groups for Adverse Drug Interactions

    News
    Patients diagnosed with chronic kidney disease (CKD) who take a lot of prescription medications, have long hospital admissions, have hypertension or who are mature adults (but younger than 60) are ... Read more
    February 20, 2017

    Limiting Salt Intake Lowers Blood Pressure in CKD Patients, Study Shows

    News
    Limiting the consumption of salt lead to reduced blood pressure in patients with chronic kidney disease (CKD), new research suggests. The findings will be published in an upcoming issue of ... Read more
    February 17, 2017

    End-Stage Renal Disease Therapeutic Tenapanor Does Well in Phase 3 Clinical Trial

    News
    Tenapanor, a therapeutic for end-stage renal disease patients who are on dialysis and have too much phosphate in their blood, was well-tolerated and met the goals of a Phase 3 ... Read more
    February 15, 2017

    Armetheon, FDA Reach Agreement Prior to New Drug Filing for Tecarfarin

    News
    Armetheon and the U.S. Food and Drug Administration (FDA) have reached an agreement for a Phase 3 trial of drug candidate Tecarfarin, prior to a new drug application (NDA) filing projected ... Read more
    February 13, 2017

    Nephrology Society and VA Join Forces on Best Approaches to Kidney Disease

    News
    The American Society of Nephrology (ASN) partnered with the U.S. Department of Veterans Affairs (VA) to host the Kidney Innovation Summit, aimed at advancing best practices and sharing insights in chronic ... Read more
    February 10, 2017

    FDA Approves Amgen’s Parsabiv for Secondary Hyperparathyroidism in Adults on Dialysis

    News
    The U.S. Food and Drug Administration (FDA) has approved Amgen’s Parsabiv (etelcalcetide) to treat adult patients with chronic kidney disease (CKD) who are on dialysis and experience secondary hyperparathyroidism (sHPT). “We are ... Read more
    February 8, 2017

    Higher Serum Levels of Klotho Protein May Protect Kidney Function, Study Finds

    News
    Higher levels of the klotho protein may protect the kidney from declining function, a new study reports. These findings suggest that klotho may serve as a potential therapeutic target for the ... Read more
    February 6, 2017

    Skin’s Sodium Content Linked to Heart Problems in Kidney Disease Patients, Study Shows

    News
    Sodium intake may be linked with the changes that occur in the heart’s left ventricle of patients with chronic kidney disease (CKD). Interventions that reduce sodium intake, such as reducing ... Read more
    February 3, 2017February 3, 2017

    Itching Caused by CKD, Often Overlooked, May Have Treatments on the Way

    News

    An article reviewing potential new treatments for the management of itching related to chronic kidney disease (CKD) has been published in the International Journal of Nephrology and Renovascular Disease.

    Read more
    February 1, 2017February 1, 2017

    Depression Often Undertreated in Kidney Disease Patients on Chronic Dialysis

    News
    Patients on chronic hemodialysis due to kidney failure often suffer from depression but they frequently show no interest in modifying or starting anti-depressant therapy, and specialists are often unwilling to ... Read more
    January 30, 2017

    EMA Starts Accelerated Review of G/P Regimen, Possible Treatment Option for Severe CKD

    News
    The European Medicines Agency (EMA) has begun an accelerated review of AbbVie’s marketing authorization application for a glecaprevir/pibrentasvir (G/P) regimen to treat major Hepatitis C virus (HCV) genotypes, and as a potential alternative ... Read more
    January 27, 2017

    Oral Iron Therapy Seen to Be Effective in Small Clinical Trial for Anemic CKD Patients

    News
    An oral iron formulation composed of ferric citrate shows potential as a treatment for anemia in patients with iron deficiency associated with chronic kidney disease (CKD). The study, “Effects of ... Read more
    January 25, 2017

    Harvard Study Reviews Impact of Affordable Care Act in Chronically Ill Patients

    News
    The Affordable Care Act (ACA), commonly known as ObamaCare, has been evaluated in a new research study regarding its impact in Americans living with chronic diseases, like chronic kidney disease ... Read more
    January 23, 2017January 23, 2017

    Espero Donates GoNitro to ISCHEMIA and ISCHEMIA-CKD Clinical Trials

    News
    Espero Pharmaceuticals will donate its GoNitro (nitroglycerin) sublingual powder to be used in two clinical trials in patients with stable ischemic heart disease, and in a subgroup of patients who also ... Read more
    January 20, 2017January 20, 2017

    NAACP Leads Effort to Raise Awareness of Kidney Disease, Care Among African-Americans

    News
    African-Americans are nearly four times more likely than white Americans to develop kidney failure, according to the National Institute of Diabetes and Digestive and Kidney Diseases, and a reason for an ... Read more
    January 18, 2017

    Leading Physician Organizations Issue New Guideline for Treating Hypertension in Older Adults

    News
    There is a new clinical practice guideline for the treatment of hypertension, often associated with chronic kidney disease (CKD), thanks to the joint work of two leading physician organizations, namely the American College ... Read more
    January 16, 2017January 16, 2017

    Tricida’s Therapy Candidate Shows Promise in Restoring Acid-base Balance in Kidney Disease Patients

    News
    Tricida‘s lead investigational drug TRC101 increased serum bicarbonate levels essential to restoring the acid-base balance in patients with chronic kidney disease (CKD) and metabolic acidosis, according to the results of a study. ... Read more
    January 13, 2017

    2 Clinical Trials Begin to Evaluate Potential Hyperkalemia Treatment

    News
    Two trials have been initiated to assess Ardelyx‘s RDX227675 as a treatment for patients with hyperkalemia, a serious condition in people with chronic kidney disease (CKD) and heart failure (HF). ... Read more
    January 11, 2017

    Early Consultation May Not Improve Short-term Survival in Kidney Patients

    News
    Early consultation with specialists failed to help elderly patients with acute kidney damage survive longer, according to a study. One reason is that many of those who see a nephrologist ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another CKD update.

    * indicates required
    Bionews Services, LLC
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • CDC kidney

      New CDC Infographic Shows 1 in 7 American Adults Now Have Chronic Kidney Disease

      June 7, 2017

    • Mayo-Baxter partnership

      Mayo Clinic and Baxter to Partner on Therapies for Kidney Disease and Other Conditions

      June 5, 2017

    • Kidney therapy survey

      Most U.S. and European Doctors Want Therapies to Keep Diabetic Kidney Patients from Having to Go on Dialysis

      June 2, 2017

    • kidney legislation

      Kidney Care Partners Applauds U.S. Bipartisan Legislation for Americans with CKD or End-stage Renal Disease

      May 31, 2017

    • About Us
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    CKD News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.